Literature DB >> 27872699

The effects of fenvalerate on hepatic and cerebral xenobiotic metabolizing enzymes in selenium and/or iodine deficient rats.

Aydan Caglayan1, Belma Kocer-Gumusel1, Pinar Erkekoglu1, Filiz Hincal1.   

Abstract

OBJECTIVES: Particularly in developing countries, selenium and/or iodine deficiencies are encountered and use of pesticides in agriculture are not well-controlled. Fenvalerate is a pyrethroid insectide used in agriculture and has applications against a wide range of pests. This study was designed to evaluate the effects of fenvalerate on hepatic and cerebral xenobiotic metabolizing enzyme activities in the presence of iodine and/or selenium deficiency on a rat model.
MATERIALS AND METHODS: Iodine and/or selenium deficiency was induced by feeding three-week-old Wistar rats with a diet containing <0.005 mg selenium kg-1, and/or administering 1% sodium perchlorate in drinking water for 7 weeks. Test groups received fenvalerate (100 mg kg-1 BW IP) for the last 7 days. Hepatic and cerebral microsomal aniline hydroxylase (CYP2E1) and cytosolic glutathione S-transferase (GST) activities were determined. Besides, hepatic NADPH-cytochrome P450 reductase (P450R), ethoxyresorufin O-deethylase (EROD, CYP1A1/1A2) and penthoxyresorufin O-depenthylase (PROD, CYP2B1/2B2), activities were also measured.
RESULTS: Fenvalerate had a general inductive effect on the hepatic and cerebral xenobiotic metabolizing enzyme activities. Moreover, enzyme activities were also altered by iodine and/or selenium deficiency, but the effects seemed to be enzyme- and tissue-specific.
CONCLUSION: The inductive effect of fenvalerate, particularly in high dose exposures, may change the metabolism of several xenobiotics, including drugs, as well as endogenous substrates. The effects may vary depending on the selenium and/or iodine status of individual.

Entities:  

Keywords:  Fenvalerate; Iodine; Selenium; Thyroid hormones; Xenobiotic metabolizing - enzymes

Year:  2016        PMID: 27872699      PMCID: PMC5110651     

Source DB:  PubMed          Journal:  Iran J Basic Med Sci        ISSN: 2008-3866            Impact factor:   2.699


  54 in total

1.  Thyroid regulation of NADPH:cytochrome P450 oxidoreductase: identification of a thyroid-responsive element in the 5'-flank of the oxidoreductase gene.

Authors:  K A O'Leary; H C Li; P A Ram; P McQuiddy; D J Waxman; C B Kasper
Journal:  Mol Pharmacol       Date:  1997-07       Impact factor: 4.436

2.  Curious about pesticide action.

Authors:  John E Casida
Journal:  J Agric Food Chem       Date:  2010-08-11       Impact factor: 5.279

3.  Some effects of selenium deficiency on the hepatic microsomal cytochrome P-450 system in the rat.

Authors:  R F Burk; B S Masters
Journal:  Arch Biochem Biophys       Date:  1975-09       Impact factor: 4.013

4.  Induction of liver microsomal NADPH cytochrome C reductase and cytochrome P-450 by some new synthetic pyrethroids.

Authors:  G P Carlson; G P Schoenig
Journal:  Toxicol Appl Pharmacol       Date:  1980-03-15       Impact factor: 4.219

Review 5.  Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction.

Authors:  Marcella Martignoni; Geny M M Groothuis; Ruben de Kanter
Journal:  Expert Opin Drug Metab Toxicol       Date:  2006-12       Impact factor: 4.481

6.  Inhibitory effect of propylthiouracil-induced hypothyroidism in rat on oxidative drug metabolism.

Authors:  K L Raheja; W G Linscheer; K Chijiiwa; M Iba
Journal:  Comp Biochem Physiol C       Date:  1985

7.  Chronic toxicity and carcinogenicity evaluation of fenvalerate in rats.

Authors:  C M Parker; D R Patterson; G A Van Gelder; E B Gordon; M G Valerio; W C Hall
Journal:  J Toxicol Environ Health       Date:  1984

8.  Selenium and drug metabolism--I. Multiple modulations of mouse liver enzymes.

Authors:  R Reiter; A Wendel
Journal:  Biochem Pharmacol       Date:  1983-10-15       Impact factor: 5.858

9.  Induction of rat brain cytochrome P450s (P450s) by deltamethrin: regional specificity and correlation with neurobehavioral toxicity.

Authors:  M Dayal; D Parmar; M Ali; A Dhawan; U N Dwivedi; P K Seth
Journal:  Neurotox Res       Date:  2001-08       Impact factor: 3.911

10.  Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.

Authors:  M E Andersen; H J Clewell; M L Gargas; F A Smith; R H Reitz
Journal:  Toxicol Appl Pharmacol       Date:  1987-02       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.